DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

"…</p><p>Results</p><p>From 2019 to 2023, the DDDs of rivaroxaban demonstrated a significant annual increase in most hospitals (<i>p</i> < 0.05). …"

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

"…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"

The ANCOVA and Post_hoc results. حسب Sadaf Sepasgozar Sarkhosh (20436143)

"…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"

CONSORT flowchart. حسب Sadaf Sepasgozar Sarkhosh (20436143)

"…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"

Time to stabilization in the vertical direction. حسب Sadaf Sepasgozar Sarkhosh (20436143)

"…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"

The description of games. حسب Sadaf Sepasgozar Sarkhosh (20436143)

"…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"

The description of balance training. حسب Sadaf Sepasgozar Sarkhosh (20436143)

"…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"

Isotype control overlays. حسب Chen Lu (135200)

"…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …"

Original uncropped blot. حسب Chen Lu (135200)

"…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …"

Raw Data. حسب Chen Lu (135200)

"…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …"

Identification of BM-MSCs. حسب Chen Lu (135200)

Olfactory function test graphical summary and results. حسب Myeongguk Jeong (16386165)

Comparison of ν_s measured and predicted estimates of the optimized GPR approach for (a) training, (b) validation, and (c) testing datasets. حسب Fahd Saeed Alakbari (10701871)

Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis حسب Lin Y.-T. (17065287)

"…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …"

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

Utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)